Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong

Respirology(2021)10.1111/resp.14191Source: DataRank Database

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong is a research paper published in Respirology (2021). On theSindex it has a DataRank of 0. It has been cited 178 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access178 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 10.16)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Carolyn A. Cohen ORCID,Samuel M. S. Cheng ORCID,Chunke Chen,Kin On Kwok ORCID,Karen Yiu

Live enrichment

PubMed:34820940 PMC:PMC8934254 OpenAlex:https://openalex.org/W3210423025

National Natural Science Foundation of China

Grant: T11‐705/21‐N

National Natural Science Foundation of China

Grant: T11‐712/19‐N

National Natural Science Foundation of China

Grant: N_HKU737/18

National Research Foundation of Korea

Grant: NRF‐2018M3A9H4055203

Fast Grant

Grant: 2161

National Research Foundation of Korea (NRF)

Grant: NRF-2018M3A9H4055203

NIAID NIH HHS

Grant: R01 AI107056

US National Institutes of Health

Grant: R01AI123926

National Natural Science Foundation of China (NSFC)/Research Grants Council (RGC) Joint Research Scheme

Grant: T11-712/19-N

Health and Medical Research Fund Commissioned Research on the Novel Coronavirus Disease (COVID-19), Hong Kong SAR

Grant: COVID-190126

NIAID NIH HHS

Grant: P01 AI120943

Health and Medical Research Fund Commissioned Research on the Novel Coronavirus Disease (COVID-19), Hong Kong SAR

Grant: COVID-190115

Guangdong Province International Scientific and Technological Cooperation Projects

Grant: 2020A0505100063

Health and Medical Research Fund Commissioned Research on the Novel Coronavirus Disease (COVID-19), Hong Kong SAR

Grant: COVID1903003

NIAID NIH HHS

Grant: HHSN272201400006C

National Natural Science Foundation of China (NSFC)/Research Grants Council (RGC) Joint Research Scheme

Grant: T11-705/21-N

National Institutes of Health

Grant: 5P01AI120943-03

Structural and Functional Characterization of the Ebola Virus Replication Complex

National Institutes of Health

Grant: 4R01AI107056-04

STRUCTURAL BASIS FOR IMMUNE EVASION BY RSV NON-STRUCTURAL PROTEINS

National Institutes of Health

Grant: 5R01AI123926-02

Multi-platform High Throughput Screens for Filoviral Replication Inhibitors

Pasteur Foundation Asia

FWCI

10.16

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://doi.org/10.1111/resp.14191

publisherhttps://doi.org/10.1111/resp.14191

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.14191

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/resp.14191

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34820940

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesBNT162 VaccineAdultHong KongHumansLeukocytes, Mononuclear

Keywords

ImmunogenicityCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmune systemVirologyImmunologyOutbreakDiseaseInfectious disease (medical specialty)Internal medicineCovid-19Sars-cov-2Coronavirus DiseaseBiontechBnt162b2SinovacCoronavacAdultCOVID-19 Vaccines610Leukocytes, MononuclearHong KongHumansORIGINAL ARTICLESBNT162 Vaccine

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being